OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer
Anna Bianchi, Iago De Castro Silva, Nilesh Deshpande, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1428-1453
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 49

Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24

Neutrophils at the Crossroads: Unraveling the Multifaceted Role in the Tumor Microenvironment
Deepika Awasthi, Aditya Sarode
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2929-2929
Open Access | Times Cited: 18

Targeting neutrophils: Mechanism and advances in cancer therapy
Shuaixi Yang, Jiachi Jia, Fuqi Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 14

Complex roles of autophagy in cancer development, immune evasion, and drug resistance
Xuegang Niu, Qi Sheng You, Kejun Hou, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101170-101170
Closed Access | Times Cited: 14

Tumor Cell–Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer
Samara P. Singh, Austin R. Dosch, Siddharth Mehra, et al.
Cancer Research (2024) Vol. 84, Iss. 8, pp. 1320-1332
Open Access | Times Cited: 13

Autotaxin–lysolipid signaling suppresses a CCL11–eosinophil axis to promote pancreatic cancer progression
Sohinee Bhattacharyya, Chet Oon, Luis Diaz, et al.
Nature Cancer (2024) Vol. 5, Iss. 2, pp. 283-298
Open Access | Times Cited: 12

Immune Cell Migration to Cancer
Allison Ryan, Minsoo Kim, Kihong Lim
Cells (2024) Vol. 13, Iss. 10, pp. 844-844
Open Access | Times Cited: 12

Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth
Katelyn L. Donahue, Hannah R. Watkoske, Padma Kadiyala, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1964-1989
Open Access | Times Cited: 11

The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma
Zheyi Wang, Yue Zhao, Yang Wo, et al.
Cancer Letters (2024) Vol. 593, pp. 216951-216951
Closed Access | Times Cited: 8

CXCR2 chemokine receptor – a master regulator in cancer and physiology
Gwendal Lazennec, Krishna Rajarathnam, Ann Richmond
Trends in Molecular Medicine (2023) Vol. 30, Iss. 1, pp. 37-55
Open Access | Times Cited: 17

QDPR deficiency drives immune suppression in pancreatic cancer
Liu Ji, Xiaowei He, Shuang Deng, et al.
Cell Metabolism (2024) Vol. 36, Iss. 5, pp. 984-999.e8
Closed Access | Times Cited: 7

Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer
Yifan Fu, Jinxin Tao, Yani Gu, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 7

The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma
Alexander Lekan, Louis M. Weiner
Cancers (2024) Vol. 16, Iss. 3, pp. 559-559
Open Access | Times Cited: 6

Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC
Chiara Musiu, Francesca Lupo, Antonio De Agostini, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6

Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 6

The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells
Juan Carlos López-Gil, Susana Garcı́a-Silva, Laura Ruiz, et al.
Gut (2024) Vol. 73, Iss. 9, pp. 1489-1508
Open Access | Times Cited: 5

Dynamic Immunoediting by Macrophages in Homologous Recombination Deficiency-Stratified Pancreatic Ductal Adenocarcinoma
Weifeng Hong, Feng Zhang, Nan Wang, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101115-101115
Closed Access | Times Cited: 5

Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer
Yifan Fu, Jinxin Tao, Tao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5

Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity
Kay Hänggi, Jie Li, Achintyan Gangadharan, et al.
Cancer Cell (2024)
Closed Access | Times Cited: 5

Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer
Lukas Klein, Mengyu Tu, Niklas Krebs, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Inflammation, microbiota, and pancreatic cancer
Xiaoliang Chen, F.W. Sun, Xuqin Wang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access

The role of tumor-associated fibroblast-derived exosomes in chemotherapy resistance of colorectal cancer and its application prospect
Meichen Liu, Teng-zheng Li, Cheng-Ming Peng
Biochimica et Biophysica Acta (BBA) - General Subjects (2025), pp. 130796-130796
Closed Access

Page 1 - Next Page

Scroll to top